Cargando…

Glycated Albumin and Glycated Albumin/HbA1c Predict the Progression of Coronavirus Disease 2019 from Mild to Severe Disease in Korean Patients with Type 2 Diabetes

Hyperglycemia is among the main risk factors for severe COVID-19. We evaluated the association of glycated albumin (GA) and GA/HbA1c ratio with progression of COVID-19 from mild to severe disease in patients with type 2 diabetes mellitus (T2DM). Our retrospective study included 129 patients aged ove...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoo, Jeongseon, Choi, Youngah, Park, Shin Ae, Seo, Ji Yeon, Ahn, Chul Woo, Han, Jaehyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9105907/
https://www.ncbi.nlm.nih.gov/pubmed/35566453
http://dx.doi.org/10.3390/jcm11092327
_version_ 1784708152327929856
author Yoo, Jeongseon
Choi, Youngah
Park, Shin Ae
Seo, Ji Yeon
Ahn, Chul Woo
Han, Jaehyun
author_facet Yoo, Jeongseon
Choi, Youngah
Park, Shin Ae
Seo, Ji Yeon
Ahn, Chul Woo
Han, Jaehyun
author_sort Yoo, Jeongseon
collection PubMed
description Hyperglycemia is among the main risk factors for severe COVID-19. We evaluated the association of glycated albumin (GA) and GA/HbA1c ratio with progression of COVID-19 from mild to severe disease in patients with type 2 diabetes mellitus (T2DM). Our retrospective study included 129 patients aged over 18 years with COVID-19 and T2DM who did not have any need of oxygen supplement. Of these, 59 patients whose COVID-19 was aggravated and required oxygen supplementation eventually were classified as having severe disease. Clinical and laboratory data were compared between mild and severe cases. The median of GA (18.4% vs. 20.95%, p = 0.0013) and GA/HbA1c (2.55 vs. 2.68, p = 0.0145) were higher in severe disease than in mild disease and positively correlated with C-reactive protein (Kendal Tau coefficient 0.200 and 0.126, respectively; all p < 0.05). Multiple logistic regression analysis showed that GA (odds ratio (OR), 1.151; 95% confidence interval (CI), 1.024–1.294) and GA/HbA1c (OR, 8.330; 95% CI, 1.786–38.842) increased the risk of severe disease. Patients with GA 20% or higher were 4.03 times more likely to progress from mild to severe disease. GA and GA/HbA1c ratio predicted progression of COVID-19 from mild to severe disease in patients with T2DM.
format Online
Article
Text
id pubmed-9105907
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-91059072022-05-14 Glycated Albumin and Glycated Albumin/HbA1c Predict the Progression of Coronavirus Disease 2019 from Mild to Severe Disease in Korean Patients with Type 2 Diabetes Yoo, Jeongseon Choi, Youngah Park, Shin Ae Seo, Ji Yeon Ahn, Chul Woo Han, Jaehyun J Clin Med Article Hyperglycemia is among the main risk factors for severe COVID-19. We evaluated the association of glycated albumin (GA) and GA/HbA1c ratio with progression of COVID-19 from mild to severe disease in patients with type 2 diabetes mellitus (T2DM). Our retrospective study included 129 patients aged over 18 years with COVID-19 and T2DM who did not have any need of oxygen supplement. Of these, 59 patients whose COVID-19 was aggravated and required oxygen supplementation eventually were classified as having severe disease. Clinical and laboratory data were compared between mild and severe cases. The median of GA (18.4% vs. 20.95%, p = 0.0013) and GA/HbA1c (2.55 vs. 2.68, p = 0.0145) were higher in severe disease than in mild disease and positively correlated with C-reactive protein (Kendal Tau coefficient 0.200 and 0.126, respectively; all p < 0.05). Multiple logistic regression analysis showed that GA (odds ratio (OR), 1.151; 95% confidence interval (CI), 1.024–1.294) and GA/HbA1c (OR, 8.330; 95% CI, 1.786–38.842) increased the risk of severe disease. Patients with GA 20% or higher were 4.03 times more likely to progress from mild to severe disease. GA and GA/HbA1c ratio predicted progression of COVID-19 from mild to severe disease in patients with T2DM. MDPI 2022-04-21 /pmc/articles/PMC9105907/ /pubmed/35566453 http://dx.doi.org/10.3390/jcm11092327 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Yoo, Jeongseon
Choi, Youngah
Park, Shin Ae
Seo, Ji Yeon
Ahn, Chul Woo
Han, Jaehyun
Glycated Albumin and Glycated Albumin/HbA1c Predict the Progression of Coronavirus Disease 2019 from Mild to Severe Disease in Korean Patients with Type 2 Diabetes
title Glycated Albumin and Glycated Albumin/HbA1c Predict the Progression of Coronavirus Disease 2019 from Mild to Severe Disease in Korean Patients with Type 2 Diabetes
title_full Glycated Albumin and Glycated Albumin/HbA1c Predict the Progression of Coronavirus Disease 2019 from Mild to Severe Disease in Korean Patients with Type 2 Diabetes
title_fullStr Glycated Albumin and Glycated Albumin/HbA1c Predict the Progression of Coronavirus Disease 2019 from Mild to Severe Disease in Korean Patients with Type 2 Diabetes
title_full_unstemmed Glycated Albumin and Glycated Albumin/HbA1c Predict the Progression of Coronavirus Disease 2019 from Mild to Severe Disease in Korean Patients with Type 2 Diabetes
title_short Glycated Albumin and Glycated Albumin/HbA1c Predict the Progression of Coronavirus Disease 2019 from Mild to Severe Disease in Korean Patients with Type 2 Diabetes
title_sort glycated albumin and glycated albumin/hba1c predict the progression of coronavirus disease 2019 from mild to severe disease in korean patients with type 2 diabetes
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9105907/
https://www.ncbi.nlm.nih.gov/pubmed/35566453
http://dx.doi.org/10.3390/jcm11092327
work_keys_str_mv AT yoojeongseon glycatedalbuminandglycatedalbuminhba1cpredicttheprogressionofcoronavirusdisease2019frommildtoseverediseaseinkoreanpatientswithtype2diabetes
AT choiyoungah glycatedalbuminandglycatedalbuminhba1cpredicttheprogressionofcoronavirusdisease2019frommildtoseverediseaseinkoreanpatientswithtype2diabetes
AT parkshinae glycatedalbuminandglycatedalbuminhba1cpredicttheprogressionofcoronavirusdisease2019frommildtoseverediseaseinkoreanpatientswithtype2diabetes
AT seojiyeon glycatedalbuminandglycatedalbuminhba1cpredicttheprogressionofcoronavirusdisease2019frommildtoseverediseaseinkoreanpatientswithtype2diabetes
AT ahnchulwoo glycatedalbuminandglycatedalbuminhba1cpredicttheprogressionofcoronavirusdisease2019frommildtoseverediseaseinkoreanpatientswithtype2diabetes
AT hanjaehyun glycatedalbuminandglycatedalbuminhba1cpredicttheprogressionofcoronavirusdisease2019frommildtoseverediseaseinkoreanpatientswithtype2diabetes